Results 201 to 210 of about 39,266 (270)

A case report of plaque psoriasis comorbid with hidradenitis suppurativa, hepatitis B, and colorectal cancer treated with xeligekimab. [PDF]

Front Immunol
Ma J, Hu B, Pan J, Liu L.
europepmc   +1 more source

Correction: Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis. [PDF]

Dermatol Ther (Heidelb)
Lebwohl MG, Carvalho A, Asahina A, Zhang J, Fazeli MS, Kasireddy E, Serafini P, Ferro T, Gogineni R, Thaçi D.   +9 more
europepmc   +1 more source

A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab. [PDF]

Nat Commun
Blauvelt A, Jiang R, Shi L, Tsoi LC, Bogle R, Fox J, Gharaee-Kermani M, Billi AC, Matheson RT, Photowala H, Gudjonsson JE, Ehst BD.   +11 more
europepmc   +1 more source

Efficacy and safety of cyclosporine a combined with acitretin in moderate-to-severe plaque psoriasis: a randomized controlled trial. [PDF]

Front Med (Lausanne)
Xu K, Yuan P, Jia S, Gong C, Hu Q, Sun J, Zhu C, Wang J, Xu S.   +8 more
europepmc   +1 more source

Does Mirikizumab benefit patients with plaque psoriasis? a systematic review and meta-analysis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Mohamed SF, Abdelraouf MR, Wagdy M, Hegazy A, Essam M, Elsekaily A.   +5 more
europepmc   +1 more source

A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards. [PDF]

Front Immunol
Hu R, Li Q, Liu X, Hu Y, Pan Y, Liu C, Lu P, Chen X, Xiong J, Zhang J, Huang K.   +10 more
europepmc   +1 more source

Indirect Comparison of Cal/BDP PAD-Cream vs Cal/BDP Foam in Patients with Plaque Psoriasis Meeting the Rule of Tens. [PDF]

Dermatol Ther (Heidelb)
Campanati A, Llamas-Velasco M, Wohlrab J, Banerjee R, Carles A, Galván J, Lorenzo-Herrero S, Cuervo J, Crespo C.   +8 more
europepmc   +1 more source

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials. [PDF]

Dermatol Ther (Heidelb)
Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M.   +9 more
europepmc   +1 more source

Bimekizumab for plaque psoriasis

, 2022
openaire   +1 more source